Clene Inc. (CLNN) stock
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.22−0.44 (-12.02%)
Close on Nov 17, 2026Market cap $41.37MP/E –Yield –
Clene cash
Cash and short-term investments held at the end of each period.
Clene's cash was $9.70M at Jun 30, 2026. For fiscal 2025 it was $5.20M, down 57.4% from the year before. The highest annual figure on record is $59.28M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.20M | -57.4% |
| FY2024 | Dec 31, 2024 | $12.20M | -65.1% |
| FY2023 | Dec 31, 2023 | $35.00M | +50.2% |
| FY2022 | Dec 31, 2022 | $23.30M | -53.7% |
| FY2021 | Dec 31, 2021 | $50.30M | -15.1% |
| FY2020 | Dec 31, 2020 | $59.28M | +574.5% |
| FY2019 | Dec 31, 2019 | $8.79M | -47.6% |
| FY2018 | Dec 31, 2018 | $16.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.70M | +32.9% |
| Q1 FY2026 | Mar 31, 2026 | $5.90M | -39.8% |
| Q4 FY2025 | Dec 31, 2025 | $5.20M | -57.4% |
| Q3 FY2025 | Sep 30, 2025 | $7.90M | -45.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.30M | -66.4% |
| Q1 FY2025 | Mar 31, 2025 | $9.80M | -64.9% |
| Q4 FY2024 | Dec 31, 2024 | $12.20M | -65.1% |
| Q3 FY2024 | Sep 30, 2024 | $14.60M | -65.3% |
| Q2 FY2024 | Jun 30, 2024 | $21.70M | -55.9% |
| Q1 FY2024 | Mar 31, 2024 | $27.90M | +51.6% |
| Q4 FY2023 | Dec 31, 2023 | $35.00M | +50.2% |
| Q3 FY2023 | Sep 30, 2023 | $42.10M | +60.2% |
| Q2 FY2023 | Jun 30, 2023 | $49.20M | +34.7% |
| Q1 FY2023 | Mar 31, 2023 | $18.40M | -63.4% |
| Q4 FY2022 | Dec 31, 2022 | $23.30M | -61.5% |
| Q2 FY2022 | Jun 30, 2022 | $26.29M | -58.3% |
| Q1 FY2022 | Mar 31, 2022 | $36.52M | -24.0% |
| Q4 FY2021 | Dec 31, 2021 | $50.30M | -15.1% |
| Q3 FY2021 | Sep 30, 2021 | $60.55M | +64.6% |
| Q2 FY2021 | Jun 30, 2021 | $63.01M | +814.6% |
| Q1 FY2021 | Mar 31, 2021 | $48.04M | +575.1% |
| Q4 FY2020 | Dec 31, 2020 | $59.28M | +574.5% |
| Q3 FY2020 | Sep 30, 2020 | $36.78M | +119.2% |
| Q2 FY2020 | Jun 30, 2020 | $6.89M | – |
| Q1 FY2020 | Mar 31, 2020 | $7.12M | – |
| Q4 FY2019 | Dec 31, 2019 | $8.79M | – |
| Q4 FY2018 | Dec 31, 2018 | $16.78M | – |
See a number that looks wrong?